Table 3.
Drugs | Flavonoid | Species in Which Tested | Change in Bioavailability |
---|---|---|---|
Diltiazem (15 mg/kg, oral) | Morin (1.5–7.5 mg/kg, oral) | Rat | 1.4- to 1.8-fold increases |
Talinolol (10 mg/kg, oral) | Naringin (1–20 mg/kg, oral) | Rat | 1.5- to 3.0-foldincreases |
Etoposide (6 mg/kg, oral) | Morin (15 mg/kg, oral) | Rat | 1.4-fold increases |
Digoxin (0.02 mg/kg, oral) | Quercetin (40 mg/kg, oral) | Pig | 1.7-foldincreases |
Moxidectin (0.2 mg/kg, subcutaneous) |
Quercetin (10 mg/kg, subcutaneous) |
Sheep | 1.8-fold increases |
Verapamil (10 mg/kg, oral) | Quercetin (15 mg/kg, oral) | Rabbit | 2-fold increases |
Paclitaxel (30 mg/kg oral) | Genistein (10 mg/kg, oral) | Rat | 1.5-fold increases |